Drug Topics March 19, 2025
Brian Nowosielski

In an Axios analysis of US Senate lobbying disclosures from the past year, researchers explored the ongoing trends of how certain industries distribute influence among legislators.

Pharmacy benefit manager (PBM), drug manufacturer, and physician trade groups all spent more on health care lobbying from 2023 to 2024, according to an Axios report.1

“In the past 5 years, the number of health care-related organizations ranked in the top 10 for lobbying spending at the state Capitol has increased significantly,” wrote David Krechevsky for the Connecticut Hospital Association.2 “There were just 2 health care-related organizations among the top 5 lobbying spenders in the 2-year period of 2019 and 2020, and just 3 among the top 10. For 2021-22, 4 of the top...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Faster Cancer Drug Approvals Tied to Clinical Benefits
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years
The Future of PBMs in 2025: AI, Regulations, and Transparency Initiatives
Q&A: Pharmacy Closures, PBM Reform, and How Pharmacists Can Effectively Advocate

Share This Article